Peyton Powell
Story Poster
Brauny's Bullets: Aggies topple Longhorns in extra-inning dogfight
6 mo ago by Ryan Brauninger
A pair of runs in the top of the 11th inning were enough for No. 3 national seed Texas A&M to take down arch-rival Texas, 4-2, and move on to Sunday's regional final. Following the twin, baseball analyst Ryan Brauninger shared his thoughts on the Aggies' performance.
Story Poster
Baseball Thoughts: A&M's rest, reminder & reset entering regional play
6 mo ago by Ryan Brauninger
Texas A&M went 0-2 at the 2024 Southeastern Conference Tournament in Hoover last week, but the Aggies will now encounter the most important weekend of the year as they prepare for the 2024 Bryan-College Station Regional at Blue Bell Park.
Story Poster
Midweek Preview: No. 7 A&M puts 11-0 start on the line vs. No. 24 Texas
9 mo ago by David Sandhop
A sold-out crowd of over 7,000 will be on hand at UFCU Disch-Falk Field in Austin when No. 7 Texas A&M makes the 105-mile journey to face the 24th-ranked Texas Longhorns. It will be the final midweek clash between the two rivals before they are again conference foes next year.
Get access to all Premium content today
Start your subscription for just $1
Try Premium Now
Story Poster
Aggies, Longhorns meet Tuesday for last of 'meaningless' midweeks
9 mo ago by Richard Zane
Next season, Texas A&M and Texas will again be conference opponents, which means the one-off midweek matchups will be no more. However, on Tuesday night in Austin, the hatred between the No. 7 Aggies and No. 24 Longhorns will be far from meaningless.
Story Poster
9:57
Texas A&M's skid continues with midweek loss to No. 21 Texas, 5-2
1 yr ago by Richard Zane
Falling into an early hole, the Aggies couldn't climb their way back into the game as they suffered their fourth straight loss, 5-2. Running through eight different pitchers, A&M struggled to take control of the mound while the offense batted just .187 on the night.
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.